Author Correction: AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition

Acta Pharmacol Sin. 2020 May;41(5):733-734. doi: 10.1038/s41401-019-0344-3.

Kai-Li Zhang^{1

2}, Qian-Qian Shen¹, Yan-Feng Fang¹, Yi-Ming Sun¹, Jian Ding³, Yi Chen⁴

¹ Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
² University of Chinese Academy of Sciences, No.19A Yuquan Road, Beijing, 100049, China.
³ Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. jding@simm.ac.cn.
⁴ Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. ychen@simm.ac.cn.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.